Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc covers the month of May 2026, specifically reporting on share buyback activities concluded on May 18, 2026. Haleon is a consumer health company focused on everyday health, with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.
Key Financial Metrics and Share Transactions
The filing details the execution of a share buyback programme announced on March 12, 2026. The Company purchased 8,316,688 ordinary shares for cancellation across multiple trading venues (London Stock Exchange, CBOE UK/BXE, CBOE UK/CXE, and Aquis) between May 11 and May 15, 2026.
| Date | Shares Purchased | Price Range (p) | VWAP (p) |
|---|---|---|---|
| May 11, 2026 | 3,179,307 | 326.60 - 333.10 | 328.52 (approx) |
| May 12, 2026 | 299,008 | 325.40 - 332.00 | 327.78 (approx) |
| May 13, 2026 | 1,600,000 | 329.90 - 331.70 | 330.91 (approx) |
| May 14, 2026 | 1,249,501 | 329.40 - 332.80 | 331.15 (approx) |
| May 15, 2026 | 1,988,872 | 329.00 - 332.30 | 330.74 (approx) |
| Total | 8,316,688 | 325.40 - 333.10 | N/A |
Following these transactions, the Company's registered share capital stands at 8,871,945,578 ordinary shares of £0.01 each. Of these, 12,130,560 are held as treasury shares, resulting in 8,859,815,018 ordinary shares with voting rights.
Note: This filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It is strictly a report on transactions in own shares.
Material Changes
The primary material change reported is the reduction in the number of outstanding shares due to the cancellation of 8,316,688 shares purchased under the ongoing buyback programme. The filing does not disclose material changes to financial performance or operational metrics compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies beyond the standard disclaimer that the announcement does not constitute an offer for securities. The Company directs investors to its website for further information.
Key Facts for Investor Verification
- Verify the total number of shares purchased (8,316,688) and the specific dates of execution (May 11-15, 2026).
- Confirm the updated share count: 8,859,815,018 shares with voting rights.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular pricing data.
- Check the Company's website (www.haleon.com/investors) for the complete trade breakdown and any additional investor updates.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly reports for revenue and earnings.